Skip to content

A randomized controlled trial to verify the effectiveness of community-based Prolonged Exposure for victims of sexual violence

A randomized controlled trial to verify the effectiveness of community-based Prolonged Exposure for victims of sexual violence - RCT to verify the effectiveness of community-based PE for victims of sexual violence

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000058527
Enrollment
34
Registered
2025-07-20
Start date
2025-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Posttraumatic Stress Disorder (PTSD)

Interventions

Online PE for sexual assault victims with PTSD Treatment-as-usual only

Sponsors

Musashino University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The subject is consulting at the community rape crisis center, and the rape crisis center staff has agreed to cooperate with this study. 2. Diagnosed with PTSD by the community psychiatric medical institution. 3. The psychiatrist has approved the subject's participation in this study, and continuation of their once or if necessary, more than once a month consultation throughout the period of the study. 4. During the course of the PE, the subject and psychiatrist have agreed that the therapist, assessor, rape crisis center staff, etc., may inquiry them regarding the treatment, prescription, etc. of the subject. 5. Using CAPS-5, the subject has been assessed with PTSD or a condition equivalent to PTSD (adjustment disorder, etc.) in relation to the identified traumatic experience. 6. The subjects is able to visit the community rape crisis center once a week. 7. The subject is able to use an online device and communicate in Japanese adequately.

Exclusion criteria

Exclusion criteria: 1. The subject has comorbid diagnosis of schizophrenia and other related disorders. 2. The subject has comorbid physical disorder in which would interfere with the treatment. 3. There is a presence of psychological symptoms (manic state of bipolar disorder and extreme emotional instability, alcohol/substance abuse/dependence, severe depressive symptoms, self-harming behaviors, suicidal attempts, etc.) for which other immediate treatment/s should be prioritized. 4. The subject has clinical history of alcohol/substance dependence or abuse within the past 6 months. 5. The subject has clinical history of suicidal attempt and serious self-harming behaviors (manipulative self-harm such as severe cut wounds, unconsciousness or overdose, etc.) within the past 6 months. 6. The subject has changes in the prescription of antidepressants and antipsychotic medications for the past month, and currently has plans in changing the prescription during the course of the treatment. 7. The subject is currently receiving any specific psychotherapeutic treatment/s other than supportive psychotherapy. 8. If the researcher determines that the subject is inappropriate

Design outcomes

Primary

MeasureTime frame
Clinician-Administered PTSD Scale for DSM-5(CAPS-5)

Secondary

MeasureTime frame
1.PTSD Checklist for DSM-5(PCL-5) 2.Beck Depression Inventory -II (BDI -II) 3.Dissociative Experiences Scale(DES) 4.Posttraumatic Cognitions Inventory(JPTCI) 5.Emergence of adverse event

Countries

Japan

Contacts

Public ContactRiek Konno

Musashino University Cognitive Behavioral Therapy and Research Institute

rkonno@musashino-u.ac.jp03-5530-7333

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026